Phase 2 study for people with Melanoma

Recruiting Phase 2

Sources: ClinicalTrials.gov Checked: 11 October 2026 Not medical advice

This trial at a glance

Status Recruiting
Phase Phase 2
Sponsor Primmune Therapeutics, Inc.
Registry number NCT07565285
Started 1 July 2026 Today 16 October 2026 Estimated completion 1 December 2027

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
Calvary Mater Newcastle Waratah NSW Recruiting
Cairns And Hinterland Hospital And Health Service Cairns QLD Not yet recruiting
Gallipoli Medical Research Greenslopes QLD Not yet recruiting
Princess Alexandra Hospital Woolloongabba QLD Not yet recruiting
Peter MacCallum Cancer Centre Melbourne VIC Not yet recruiting
One Clinical Research Pty Ltd Nedlands WA Recruiting
Sir Charles Gairdner Hospital Nedlands WA Not yet recruiting

voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice

Who can join

Age 18 Years and over
Sex Anyone, regardless of sex
Healthy volunteers Not accepted
Enrolment target 48

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Inclusion Criteria:

* Adults aged 18 years or older

* Histologically confirmed, resectable Stage III cutaneous melanoma.

* Candidate for curative-intent surgical resection

* Eastern Cooperative Oncology Group (ECOG) performance status of 0-2

* Adequate organ function

* Able to provide written informed consent

Exclusion Criteria:

* Prior systemic therapy for melanoma, including immunotherapy

* Uveal melanoma or mucosal melanoma.

* Active autoimmune disease requiring systemic treatment

* Primary immunodeficiency or use of systemic immunosuppressive therapy

* Women who are pregnant or breastfeeding

* Recent treatment with another investigational therapy

* Any condition that, in the opinion of the investigator, would interfere with study participation or safety

Dates on the record

Started 1 July 2026
Estimated completion 1 December 2027
Registry last updated 19 August 2026
Checked by Voxsanity 11 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 19 August 2026.
  • This page last checked by Voxsanity: 11 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.